Pancuronium and speech disorder developmental Patient Reports February 13, 2012

Pancuronium Side Effects Report #5362648-X
Pancuronium side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2007. Male patient, child 3 years of age, was diagnosed with mechanical ventilation and was treated with Pancuronium. After drug was administered, patient experienced the following side effects: deafness neurosensory, hearing aid user, renal failure acute, speech disorder developmental. Pancuronium dosage: 4.8 MG QD, INTRAVENOUS DRIP. During the same period patient was treated with CEFMETAZOLE, ULINASTATIN, FAMOTIDINE, DOBUTAMINE HYDROCHLORIDE, DOPAMINE, FENTANYL CITRATE, DEXAMETHASONE, BICARBONATE. Patient recovered.

Pancuronium Side Effects Report #5362654-5
Pancuronium side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2007. Male patient was diagnosed with mechanical ventilation and was treated with Pancuronium. After drug was administered, patient experienced the following side effects: deafness neurosensory, gastrooesophageal reflux disease, hearing aid user, speech disorder developmental. Pancuronium dosage: unknown. During the same period patient was treated with MENATETRENONE, CARBAZOCHROME SULFONATE, TRANEXAMIC ACID, CALCIUM GLUCONATE, DEXAMETHASONE, CEFMETAZOLE, ULINASTATIN. Patient recovered.

Pancuronium Side Effects Report #4726260-5
Pancuronium side effect was reported by a Physician from JAPAN on July 14, 2005. Male patient, child 3 years of age, was diagnosed with life support and was treated with Pancuronium. After drug was administered, patient experienced the following side effects: deafness neurosensory, renal failure acute, speech disorder developmental. Pancuronium dosage: unknown. During the same period patient was treated with NITROUS OXIDE, LOOP DIURETIC. Patient recovered.

Pancuronium Side Effects Report #4847478-7
Pancuronium side effect was reported by a Health Professional from JAPAN on Nov 21, 2005. Male patient, child 3 years of age, was diagnosed with life support and was treated with Pancuronium. After drug was administered, patient experienced the following side effects: deafness neurosensory, renal failure acute, speech disorder developmental. Pancuronium dosage: 4.8 MG QD. During the same period patient was treated with CEPMETAZOLE, ULINASTATIN, FAMOTIDINE, DOBUTAMINE, DOPAMINE, FENTANYL CITRATE, DEXAMETHASONE, BICARBONATE. Patient recovered.


Pancuronium Side Effects Report #4847477-5
Pancuronium side effect was reported by a Consumer or non-health professional from JAPAN on Nov 21, 2005. Male patient was diagnosed with life support and was treated with Pancuronium. After drug was administered, patient experienced the following side effects: deafness neurosensory, speech disorder developmental. Pancuronium dosage: 0.3 MG S1HR/0.2 MG Q1HR. During the same period patient was treated with MENATETRENONE, CARBAZOCHROME SULFONATE, TRANEXAMIC ACID, CALCIUM GLUCONATE, DEXAMETHASONE, CEFMETAZOLE, ULINASTATIN. Patient recovered.